Dianthus Therapeutics Inc
NASDAQ:DNTH

Watchlist Manager
Dianthus Therapeutics Inc Logo
Dianthus Therapeutics Inc
NASDAQ:DNTH
Watchlist
Price: 41.21 USD 0.61% Market Closed
Market Cap: 1.8B USD

Operating Margin
Dianthus Therapeutics Inc

-4 558.4%
Current
-1 764%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-4 558.4%
=
Operating Profit
-140.3m
/
Revenue
3.1m

Operating Margin Across Competitors

No Stocks Found

Dianthus Therapeutics Inc
Glance View

Market Cap
1.8B USD
Industry
Biotechnology

Dianthus Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts and currently employs 67 full-time employees. The company went IPO on 2018-06-21. Dianthus Therapeutics, Inc., formerly Magenta Therapeutics, Inc., is a clinical-stage biotechnology company engaged in designing and delivering monoclonal antibodies. The Company’s lead antibody, DNTH103, is engineered with an extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology, enabling less frequent and more convenient self-administered subcutaneous injections. DNTH103 is an investigational, long-acting monoclonal antibody engineered to potently and selectively inhibit the active form of C1s, a clinically validated target in the classical complement pathway. As the classical pathway plays a significant role in disease pathology across a range of neuromuscular disorders, DNTH103 holds the potential to be a pipeline in a product beginning with generalized Myasthenia Gravis (gMG), Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating Polyneuropathy.

DNTH Intrinsic Value
0.46 USD
Overvaluation 99%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-4 558.4%
=
Operating Profit
-140.3m
/
Revenue
3.1m
What is the Operating Margin of Dianthus Therapeutics Inc?

Based on Dianthus Therapeutics Inc's most recent financial statements, the company has Operating Margin of -4 558.4%.

Back to Top